Tag Archives: Roche results

Investec Switzerland. Roche Holding AG’s third-quarter revenue rose 4.5 percent as its trio of breast-cancer therapies offset stagnating sales of some of its older drugs. Sales climbed to 12.5 billion Swiss francs ($12.6 billion), the Basel, Switzerland-based company said in a statement on Thursday. That compared with the 12.6 billion-franc average estimate of nine analysts surveyed by Bloomberg. Roche doesn’t report third-quarter earnings. The world’s biggest...

Read More »